Table 2. Low-, moderate-, and high-efficacy treatments for multiple sclerosis56.
Low-efficacy treatments | Moderate-efficacy treatments | High-efficacy treatments |
---|---|---|
• Interferons | • Cladribine* | • Ocrelizumab |
• Glatiramer acetate | • s1p inhibitors* | • Ofatumumab |
• Teriflunomide | • Fumarates | • Natalizumab |
• Alemtuzumab |
*May be considered to have moderate-to-high efficacy.